Oncology – Gastrointestinal
Retrospective Cohort Study: Colonoscopy surveillance following adenoma removal to reduce the risk of colorectal cancer.
1 Jun, 2022 | 11:17h | UTC
Update on perioperative management of patients undergoing surgery for liver cancer.
1 Jun, 2022 | 11:11h | UTC
Long-term impact of Helicobacter pylori eradication therapy on gastric cancer incidence and mortality in healthy infected individuals: A meta-analysis beyond 10 years of follow-up.
31 May, 2022 | 11:47h | UTC
Commentary from the author on Twitter (thread – click for more)
https://twitter.com/alex_ford12399/status/1527601814765551616
RCT: Rivaroxaban vs. placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer.
31 May, 2022 | 11:19h | UTC
Current guidelines in the surgical management of hereditary colorectal cancers.
27 May, 2022 | 12:00h | UTC
Cohort Study: Age at initiation of lower gastrointestinal endoscopy and colorectal cancer risk.
27 May, 2022 | 11:26h | UTCAge at Initiation of Lower Gastrointestinal Endoscopy and Colorectal Cancer Risk Among US Women – JAMA Oncology (link to abstract – $ for full-text)
Commentaries:
Related:
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
ACG Clinical Guidelines: Colorectal Cancer Screening 2021 – The American Journal of Gastroenterology
Screening and prevention of colorectal cancer – The BMJ
Current and future colorectal cancer screening strategies – Nature Reviews Gastroenterology & Hepatology (if the link is paywalled, try this one in PMC)
Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study – The Lancet Gastroenterology & Hepatology (link to abstract – $ for full-text)
Commentary on Twitter
https://twitter.com/JAMAOnc/status/1522244731899629571
Position Paper: Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer.
26 May, 2022 | 10:42h | UTC
Observational study suggests hepatic arterial infusion pump chemotherapy may be an alternative to resection for patients with multifocal intrahepatic cholangiocarcinoma.
23 May, 2022 | 00:52h | UTCComparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic Cholangiocarcinoma – JAMA Surgery (link to abstract – $ for full-text)
Commentaries:
Treating iCCA With Chemo Pump Can Be as Effective as Surgery, JAMA Study Finds – AJMC
Commentaries on Twitter
https://twitter.com/JAMASurgery/status/1524872044827000836
https://twitter.com/SyedAAhmad5/status/1527034049721663489
Review | Esophageal adenocarcinoma: A dire need for early detection and treatment.
19 May, 2022 | 10:24h | UTC
The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: A population-based modelling study.
19 May, 2022 | 10:19h | UTC
[News release – not published yet] Gallstone disease shown to be a strong predictor of pancreatic cancer.
16 May, 2022 | 01:49h | UTC
Guideline for Pancreatic Cancer: A summary of evidence-based surgical approaches.
12 May, 2022 | 10:09h | UTC
M-A: Chemoradiotherapy followed by active surveillance vs. standard esophagectomy for esophageal cancer.
12 May, 2022 | 07:51h | UTCChemoradiotherapy Followed by Active Surveillance Versus Standard Esophagectomy for Esophageal Cancer: A Systematic Review and Individual Patient Data Meta-analysis – Annals of Surgery (link to abstract – $ for full-text)
Guideline: Endoscopic submucosal dissection for superficial gastrointestinal lesions.
10 May, 2022 | 10:53h | UTC
RCT: Final analysis of 3 vs. 6 months of adjuvant Oxaliplatin and Fluoropyrimidine-based therapy in patients with Stage III colon cancer.
10 May, 2022 | 10:40h | UTC
Commentaries on Twitter
https://twitter.com/drkpavithran/status/1522370036072996865
M-A: Comparison of survival among adults with rectal cancer who have undergone laparoscopic vs. open surgery.
10 May, 2022 | 10:43h | UTC
Commentary on Twitter
This meta-analysis of 12 RCTs found laparoscopic rectal cancer resection is associated with better long-term overall survival vs open surgery, suggesting it may be time for routine use of laparoscopic surgery for rectal cancer. https://t.co/jb7YAkHDWM
— JAMA Network Open (@JAMANetworkOpen) May 9, 2022
Current and future colorectal cancer screening strategies.
10 May, 2022 | 10:34h | UTCCurrent and future colorectal cancer screening strategies – Nature Reviews Gastroenterology & Hepatology (if the link is paywalled, try this one in PMC)
M-A: Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment.
3 May, 2022 | 10:33h | UTC
RCT: Tislelizumab vs. chemotherapy as second-line treatment for advanced or metastatic esophageal squamous cell carcinoma.
3 May, 2022 | 10:36h | UTC
Commentary on Twitter
In the phase III RATIONALE-302 trial of tislelizumab vs chemotherapy as 2nd-line therapy for advanced-stage ESCC, mOS was 8.6 vs 6.3 months (HR 0.70; P=0.0001), rising to 10.3 vs 6.8 months for those with a PD-L1 tumour area positivity score >10%: https://t.co/CNxads2Kn2 #esocsm
— NatureRevClinOncol (@NatRevClinOncol) April 27, 2022
Clinical management of metastatic colorectal cancer in the era of precision medicine.
1 May, 2022 | 23:27h | UTC
RCT: Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy.
1 May, 2022 | 23:20h | UTC
Evidence-based approach to the treatment of esophagogastric junction tumors.
29 Apr, 2022 | 08:12h | UTC
NCCN Guideline: Gastric Cancer.
29 Apr, 2022 | 08:05h | UTC
Consensus Statement: Diagnosis and management of cancer risk in the gastrointestinal hamartomatous polyposis syndromes.
28 Apr, 2022 | 10:35h | UTC
Critical analysis of the updated guidelines for management of gallbladder polyps.
26 Apr, 2022 | 07:41h | UTCCritical Analysis of the Updated Guidelines for Management of Gallbladder Polyps – Annals of Surgical Oncology (if the link is paywalled, try this one)